/KVUE

KVUE Stock - Kenvue Inc.

Q: What is the analyst price target for KVUE?

Analyst price target information is not currently available for KVUE.

Q: What is KVUE's market cap?

Market capitalization information is not currently available for KVUE.

Consumer Defensive|Household & Personal Products|NYSE

$17.01+0.06%

+$0.01 (+0.06%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+8.8%upside

Target: $18.51

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for KVUE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.55

52W High$25.17

52W Low$14.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$15.46B	$15.44B	$14.95B	$15.05B	$14.47B
Gross Profit	$8.96B	$8.64B	$8.29B	$8.42B	$7.85B
Gross Margin	58.0%	56.0%	55.4%	55.9%	54.2%
Operating Income	$1.84B	$2.51B	$2.67B	$2.92B	$-979,000,000
Net Income	$1.03B	$1.66B	$2.06B	$2.08B	$-879,000,000
Net Margin	6.7%	10.8%	13.8%	13.8%	-6.1%
EPS	$0.54	$0.90	$1.08	$1.10	$-0.47

Company Overview

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Visit Website

Earnings History & Surprises

KVUE

Beat Rate

82%

Last 11 quarters

Avg Surprise

+2.5%

EPS vs Estimate

Beats / Misses

9/1

1 met exactly

Latest EPS

$0.28

Q4 2025

EPS Surprise History

Q1 24

+9.5%

$0.31vs$0.28

Q2 24

+10.2%

$0.28vs$0.25

Q3 24

+16.1%

$0.32vs$0.28

Q4 24

+2.8%

$0.28vs$0.27

Q1 25

0.0%

$0.26vs$0.26

Q2 25

+5.5%

$0.24vs$0.23

Q3 25

+2.9%

$0.29vs$0.28

Q4 25

+7.6%

$0.28vs$0.26

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Feb 5, 2026	$0.22	—	—	—
Q4 2025	Nov 3, 2025	$0.26	$0.28	+7.6%	✓ BEAT
Q3 2025	Aug 7, 2025	$0.28	$0.29	+2.9%	✓ BEAT
Q2 2025	May 8, 2025	$0.23	$0.24	+5.5%	✓ BEAT
Q1 2025	Feb 6, 2025	$0.26	$0.26	0.0%	= MET
Q4 2024	Nov 7, 2024	$0.27	$0.28	+2.8%	✓ BEAT
Q3 2024	Aug 6, 2024	$0.28	$0.32	+16.1%	✓ BEAT
Q2 2024	May 7, 2024	$0.25	$0.28	+10.2%	✓ BEAT
Q1 2024	Feb 8, 2024	$0.28	$0.31	+9.5%	✓ BEAT
Q4 2023	Oct 26, 2023	$0.30	$0.31	+3.3%	✓ BEAT
Q3 2023	Jul 20, 2023	$0.29	$0.32	+10.3%	✓ BEAT
Q2 2023	May 3, 2023	$0.32	$0.19	-40.6%	✗ MISS
Q1 2023	Jan 1, 2023	—	$0.21	—	—
Q4 2022	Oct 2, 2022	—	$0.34	—	—
Q3 2022	Jul 3, 2022	—	$0.32	—	—
Q1 2022	Mar 31, 2022	—	$0.28	—	—
Q4 2021	Dec 31, 2021	—	$0.22	—	—

Frequently Asked Questions about KVUE

What is KVUE's current stock price?

Kenvue Inc. (KVUE) is currently trading at $17.01 per share. The stock has moved +0.06% today.

What is the analyst price target for KVUE?

The average analyst price target for KVUE is $18.50, based on 1 analyst.

What sector is Kenvue Inc. in?

Kenvue Inc. operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the NYSE exchange.

What is KVUE's market cap?

Kenvue Inc. has a market capitalization of $32.60 billion, making it a large-cap company.

Does KVUE pay dividends?

No, Kenvue Inc. does not currently pay a dividend to shareholders.